Publications

Showing a curated list, last updated manually.

2026

Re-emergence of vaccine-preventable diseases in the post-elimination era.

PLoS Medicine

Kumar CK, Lo NC. 23(7):e1005175.

View
2026

Trends in County-Level Childhood Vaccination Exemptions in the US.

JAMA

Fattah M, Stoffel LA, Bubar KM, Bents SJ, Maldonado Y, Hotez PJ, Kiang MV, Lo NC.

View
2025

Modeling the Health Impact of Discontinuing COVID-19 Vaccination During Pregnancy in the US.

JAMA Pediatrics

Lo NC, Maldonado Y, Chu HY, Hotez PJ, Kiang MV.

View
2025

Population-level impact of mass drug administration against schistosomiasis with anthelmintic drugs targeting juvenile schistosomes: a modelling study.

The Lancet Microbe

Singer BJ, Gomes M, Coulibaly JT, Daigavane M, Tan ST, Bogoch II, Lo NC.

View
2025

Modeling Reemergence of Vaccine-Eliminated Infectious Diseases Under Declining Vaccination in the US.

JAMA

Kiang MV, Bubar KM, Maldonado Y, Hotez PJ, Lo NC.

View
2025

Strength and durability of indirect protection against SARS-CoV-2 infection through vaccine and infection-acquired immunity.

Nature Communications

Tan ST, Rodriguez-Barraquer I, Kwan AT, Blumberg S, Park HJ, Hutchinson J, Leidner D, Lewnard JA, Sears D, Lo NC. 16(1):1090.

View
2024

Nathan Lo, translating infectious disease models into policy.

The Lancet Infectious Diseases (Profile)

Kirby T. 24(11):1196.

View
2024

Review of the WHO guideline on preventive chemotherapy for public health control of strongyloidiasis.

The Lancet Infectious Diseases

Lo NC, Addiss DG, Buonfrate D, et al.

View
2024

Comparing frequency of booster vaccination to prevent severe COVID-19 by risk group in the United States.

Nature Communications

Park HJ, Gonsalves GS, Tan ST, Kelly JD, Rutherford GW, Wachter RM, Schechter R, Paltiel AD, Lo NC. 15(1):1883.

View
2024

Development of prediction models to identify hotspots of schistosomiasis in endemic regions to guide mass drug administration.

Proceedings of the National Academy of Sciences of the United States of America

Singer BJ, Coulibaly JT, Park HJ, Andrews JR, Bogoch II, Lo NC. 121(2):e2315463120.

View
2024

WHO guideline on preventive chemotherapy for public health control of strongyloidiasis.

World Health Organization (Guideline)

WHO Guideline Development Group.

View
2023

Outbreaks in U.S. Migrant Detention Centers: A Vaccine-Preventable Cause of Health Inequity.

New England Journal of Medicine

Lo NC, Gonsalves GS.

View
2023

Infectiousness of SARS-CoV-2 breakthrough infections and reinfections during the Omicron wave.

Nature Medicine

Tan ST, Kwan AT, Rodriguez-Barraquer I, Singer BJ, Park HJ, Lewnard JA, Sears D, Lo NC. 29(2):358-365.

View
2022

Review of 2022 WHO guidelines on the control and elimination of schistosomiasis.

The Lancet Infectious Diseases

Lo NC, Bezerra FS, Colley DG, et al. 22(11):e327-e335.

View
2022

COVID-19 Vaccination and Estimated Public Health Impact in California.

JAMA Network Open

Tan ST, Park HJ, Rodriguez-Barraquer I, Rutherford GW, Bibbins-Domingo K, Schechter R, Lo NC. 5(4):e228526.

View
2022

WHO guideline on control and elimination of human schistosomiasis.

World Health Organization (Guideline)

WHO Guideline Development Group.

View
2021

Routine asymptomatic testing strategies for airline travel during the COVID-19 pandemic: a simulation study.

The Lancet Infectious Diseases

Kiang MV, Chin ET, Huynh BQ, Chapman LA, Rodriguez-Barraquer I, Greenhouse B, Rutherford GW, Bibbins-Domingo K, Havlir D, Basu S, Lo NC.

View
2020

Influenza, Varicella, and Mumps Outbreaks in US Migrant Detention Centers.

JAMA

Lo NC, Nyathi S, Chapman LA, Rodriguez-Barraquer I, Kushel M, Bibbins-Domingo K, Lewnard JA.

View
2020

Frequency of Routine Testing for Coronavirus Disease 2019 (COVID-19) in High-risk Healthcare Environments to Reduce Outbreaks.

Clinical Infectious Diseases

Chin ET, Huynh BQ, Chapman LA, Murrill M, Basu S, Lo NC.

View
2020

Childhood vaccines and antibiotic use in low- and middle-income countries.

Nature

Lewnard JA, Lo NC, Arinaminpathy N, Frost I, Laxminarayan R. 581(7806):94-99.

View
2019

The 2016 California policy to eliminate nonmedical vaccine exemptions and changes in vaccine coverage: An empirical policy analysis.

PLoS Medicine

Nyathi S, Karpel HC, Sainani KL, Maldonado Y, Hotez PJ, Bendavid E, Lo NC. 16(12):e1002994.

View
2019

State of deworming coverage and equity in low-income and middle-income countries using household health surveys: a spatiotemporal cross-sectional study.

The Lancet Global Health

Lo NC, Heft-Neal S, Coulibaly JT, Leonard L, Bendavid E, Addiss DG.

View
For the complete, continuously updated publication list, visit Nathan Lo's Stanford Profile.